Merja Haikola

Comptroller/Controller/Auditor en BBS-BIOACTIVE BONE SUBSTITUTES OYJ .

Health Technology

Perfil

Merja Haikola is currently the Accountable Director at BBS-Bioactive Bone Substitutes Plc since 2023.
Previously, she worked as a Principal at AKELA Pharma Oy from 1988 to 2003, at Leiras Oy as a Principal, and at Cancer Targeting Technologies Oy as a Principal from 2003 to 2006.

Cargos activos de Merja Haikola

Empresas	Cargo	Inicio
BBS-BIOACTIVE BONE SUBSTITUTES OYJ	Comptroller/Controller/Auditor	23/12/2023

Todos los cargos activos de Merja Haikola

Antiguos cargos conocidos de Merja Haikola.

Empresas	Cargo	Fin
Cancer Targeting Technologies Oy Cancer Targeting Technologies Oy Pharmaceuticals: MajorHealth Technology Cancer Targeting Technologies Oy used to develop anticancer drugs and drug delivery systems based on cancer specific peptides and peptide liposomes. It was also developed diagnostic tools. The company was located in Helsinki, Finland	Corporate Officer/Principal	01/01/2006
AKELA Pharma Oy AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million.	Corporate Officer/Principal	01/01/2003
Leiras Oy Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Merja Haikola.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Merja Haikola.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
BBS-BIOACTIVE BONE SUBSTITUTES OYJ	Health Technology

Empresas privadas	3
AKELA Pharma Oy AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million.	Health Technology
Cancer Targeting Technologies Oy Cancer Targeting Technologies Oy Pharmaceuticals: MajorHealth Technology Cancer Targeting Technologies Oy used to develop anticancer drugs and drug delivery systems based on cancer specific peptides and peptide liposomes. It was also developed diagnostic tools. The company was located in Helsinki, Finland	Health Technology
Leiras Oy Leiras Oy Pharmaceuticals: MajorHealth Technology Part of Bayer AG, Leiras Oy is a Finnish company that develops pharmaceutical solutions. The company is based in Turku, Finland. Leiras was acquired by Nycomed Pharma Holding A/S on May 31, 2003 for $49.44 million.	Health Technology

Ver las conexiones de la empresa